Figure 6.
Scatter and trend plot of 16 potential biomarkers in the ESI+ and ESI- models. The scatter and trend plot of acrylic acid (A), 3b-hydroxy-5-cholenoic acid (B), 5-amino-3-oxohexanoate (C), cytidine (D), D-ribose (E), L-glutamic acid (F), PE [P-18:1(9Z)/16:1(9Z)] (G), PE [P-18:1(9Z)/20:3(5Z,8Z,11Z)] (H), PE [P-18:1(11Z)/18:2(9Z,12Z)] (I), PE [P-18:1(11Z)/18:3(6Z,9Z,12Z)] (J), sorbitol (K), sphinganine (L), succinic acid semialdehyde (M), succinic acid (N), uracil (O), and uridine (P), and the ordinate was the relative intensity of metabolite. (Q,R) Receiver operator curve (ROC) analysis of the random forest model combining 12 biomarkers (P < 0.05) to diagnose MTS in the validation data. *P < 0.05, **P < 0.01.